Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
June 17 2021 - 6:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2021 (No. 2)
Commission File Number 001-37846
CELLECT BIOTECHNOLOGY LTD.
(Translation of registrant’s name into English)
23 Hata’as Street
Kfar Saba, Israel 44425
(Address of principal executive
offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
The press release attached hereto as Exhibit 99.1
entitled “Cellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin Pharmaceuticals:
Transaction Expected to Close in the 2021 Third Quarter” is hereby incorporated by reference into the Registrant’s Registration
Statements on Form S-8 (Registration Nos. 333-214817, 333-220015, 333-225003 and 333-232230) and on Form F-3 (Registration Nos. 333-219614
and 333-229083).
SIGNATURE
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
CELLECT BIOTECHNOLOGY, LTD.
|
|
|
Date: June 16, 2021
|
By:
|
/s/ Eyal Leibovitz
|
|
|
Eyal Leibovitz
Chief Financial Officer
|
3
Cellect Biotechnology (NASDAQ:APOP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cellect Biotechnology (NASDAQ:APOP)
Historical Stock Chart
From Apr 2023 to Apr 2024